CAD 0.04
(16.67%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -778.83 Thousand CAD | 2.75% |
2022 | -786.73 Thousand CAD | 1.84% |
2021 | -2.38 Million CAD | 24.94% |
2020 | -1.16 Million CAD | -28.19% |
2019 | -799.29 Thousand CAD | -103.02% |
2018 | -409.68 Thousand CAD | -1533.72% |
2017 | 69.71 Thousand CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -129.42 Thousand CAD | 62.04% |
2024 Q1 | -151.69 Thousand CAD | 12.76% |
2023 Q4 | -220.38 Thousand CAD | -37.89% |
2023 Q2 | -251.7 Thousand CAD | -52.83% |
2023 FY | - CAD | 2.75% |
2023 Q1 | -164.69 Thousand CAD | 7.23% |
2023 Q3 | -159.82 Thousand CAD | 36.5% |
2022 Q2 | -214.3 Thousand CAD | -8.01% |
2022 Q4 | -177.53 Thousand CAD | 9.14% |
2022 FY | - CAD | 1.84% |
2022 Q1 | -198.4 Thousand CAD | 13.14% |
2022 Q3 | -195.39 Thousand CAD | 8.83% |
2021 FY | - CAD | 24.94% |
2021 Q2 | -211.91 Thousand CAD | -33.4% |
2021 Q4 | -228.43 Thousand CAD | -13.57% |
2021 Q3 | -201.14 Thousand CAD | 5.08% |
2021 Q1 | -158.85 Thousand CAD | 19.09% |
2020 Q4 | -196.32 Thousand CAD | 0.17% |
2020 Q3 | -196.67 Thousand CAD | 67.25% |
2020 Q2 | -600.47 Thousand CAD | -432.55% |
2020 FY | - CAD | -28.19% |
2020 Q1 | -112.75 Thousand CAD | 62.32% |
2019 Q2 | -194.15 Thousand CAD | -31.36% |
2019 Q1 | -147.8 Thousand CAD | -8.15% |
2019 FY | - CAD | -103.02% |
2019 Q4 | -299.22 Thousand CAD | -54.93% |
2019 Q3 | -193.13 Thousand CAD | 0.53% |
2018 Q2 | -127.97 Thousand CAD | -69.62% |
2018 Q3 | -69.61 Thousand CAD | 45.6% |
2018 FY | - CAD | -1533.72% |
2018 Q4 | -136.66 Thousand CAD | -96.32% |
2018 Q1 | -75.44 Thousand CAD | -43.65% |
2017 Q4 | -52.52 Thousand CAD | -13648.69% |
2017 FY | - CAD | 0.0% |
2017 Q3 | -382.00 CAD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | 87.177% |
Ayurcann Holdings Corp. | -2.01 Million CAD | 61.262% |
Blueberries Medical Corp. | -1.22 Million CAD | 36.255% |
The BC Bud Corporation | -1.19 Million CAD | 34.881% |
BioNxt Solutions Inc. | -6.48 Million CAD | 87.99% |
CordovaCann Corp. | -1.6 Million CAD | 51.403% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | 70.313% |
Captor Capital Corp. | 2.42 Million CAD | 132.168% |
City View Green Holdings Inc. | -2.01 Million CAD | 61.338% |
1CM Inc. | 1.31 Million CAD | 159.293% |
Global Hemp Group Inc. | -24.79 Thousand CAD | -3041.338% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 64.733% |
IM Cannabis Corp. | -2.79 Million CAD | 72.085% |
Lobe Sciences Ltd. | -4.4 Million CAD | 82.308% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -98.572% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 75.608% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | 168.223% |
Pharmadrug Inc. | -1.33 Million CAD | 41.661% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | 87.14% |
RAMM Pharma Corp. | -6.3 Million CAD | 87.642% |
RIV Capital Inc. | -20.28 Million CAD | 96.16% |
Revive Therapeutics Ltd. | -5.59 Million CAD | 86.08% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 98.996% |
SLANG Worldwide Inc. | -2.95 Million CAD | 73.605% |
1933 Industries Inc. | -10.03 Million CAD | 92.237% |
Red Light Holland Corp. | -5.25 Million CAD | 85.182% |
Top Strike Resources Corp. | -767.99 Thousand CAD | -1.411% |
Xebra Brands Ltd. | -1.49 Million CAD | 47.904% |
Adastra Holdings Ltd. | -1.41 Million CAD | 44.813% |